Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
What Elevance Actually Said, and What It Means for Your Claims
On the January 28, 2026 Q4 earnings call, Elevance Health CEO Gail Boudreaux told investors the company will use analytics to flag outlier utilization and billing in high-cost substance use disorder settings, then act on those flags with provider education, claims review changes, and payment accuracy enforcement. If you run a SUD or mental health program contracted with Anthem, Wellpoint, or any Elevance Medicaid plan, treat that statement as your 90-day operational warning.
Boudreaux’s exact framing on the call: “In Medicaid, we’re strengthening our analytics to identify outlier utilization and billing patterns in high-cost substance use disorder treatment settings while maintaining access to clinically appropriate care.” She added that the insights will drive “targeted actions, including provider education, claims review enhancements, and payment accuracy and compliance initiatives where appropriate.”
Two things to notice. First, the trigger is Medicaid margin pressure: Elevance is forecasting a Medicaid operating margin of approximately negative 1.75% and 750,000 lost members in 2026. Second, Elevance reported $5.66 billion in 2025 net income on those headwinds, and SUD and ABA were singled out by President Felicia Norwood as inflated utilization drivers. The cost-recovery target is named. It is you.
The Carelon Payment Integrity Machine Is Already Built
This is not a future-state announcement. Carelon Insights (formerly Carelon Payment Integrity) has been deploying AI-driven lead identification against behavioral health claims for years. Elevance has stated publicly that one Carelon clinical auditing program cut medical record review time from 40 minutes to 20 minutes across an annualized volume of nearly 23,000 reviews. Twice the throughput, same staff.
Beth Franke, staff vice president of Elevance’s Special Investigations Unit, has been blunt about the workflow: “Advanced analytics and data-driven insights help guide our investigative strategy. When indicators suggest elevated risk, our team conducts a focused review to determine if fraud, waste, or abuse is occurring.” Read that sentence twice. The analytics are the trigger. The SIU audit is the response.
Operators should expect the same pattern other payers have run for years:
- Pre-payment claim edits on the codes Carelon flags as outliers
- Retrospective focused audits with broad date ranges
- Medical-necessity documentation requests tied to ASAM Criteria, 4th Edition placement
- SIU referrals and recoupment demands
- Provider re-education letters that double as audit predicates
The Federal Data Tells You Where the Targets Are
If you want to know what Carelon’s models will flag, look at what federal auditors already flag. CMS reported that the FY2024 Medicaid improper payment rate was 5.09%, or $31.10 billion, and 79.11% of those improper payments were the result of insufficient documentation. That is the single largest target on a payer’s heat map: services that probably happened but cannot be defended on paper.
The pattern repeats at the state level. In Ohio in December 2025, the state auditor concluded that an Akron-area behavioral health agency was paid $14.9 million for 114,800 SUD, mental health, and professional services from 2021 to 2023, and recommended repayment of nearly $2 million tied to treatment plans that did not authorize the services billed, missing documentation, and services exceeding daily limitations. HHS-OIG has hit the same vein from the federal side, finding that Colorado made at least $77.8 million in improper Medicaid payments for ABA and that Maine made at least $45.6 million in improper payments for autism-related rehabilitative and community support services. Same root cause every time: documentation that did not support the claim.
The Texas HHS OIG’s FY2025 audit plan explicitly lists behavioral health and SUD treatment facilities as provider audit topics. Carelon will not need to invent a methodology. It will copy one.
What to Fix Before the Pre-Payment Edits Land
For multi-state operators we work with in Florida, Tennessee, Arizona, and Indiana, the readiness conversation is the same. The exposure points are predictable. Fix them in this order.
- Medical necessity tied to ASAM Criteria, 4th Edition. Every admission to Level 3.7 medically-monitored intensive inpatient, Level 3.5 clinically managed high-intensity residential, Level 2.5 partial hospitalization (outpatient), and Level 2.1 intensive outpatient must trace cleanly to the six dimensions. Carelon’s reviewers will not give credit for clinical judgment that is not written down.
- Length-of-stay defensibility. Census pressure tempts programs to extend stays. Outlier LOS against peer benchmarks is the single fastest way to draw an SIU audit. If your average residential LOS is materially above your state’s Medicaid managed care norm, you need utilization management notes that justify each extension.
- Billing-code intensity. Frequency of H0015, H0010, H0035, group versus individual ratios, drug testing units. HHS-OIG found a 58.9% improper payment rate for the highest-cost Medicare drug test code in 2019, on $180 million in spending for 274,000 SUD beneficiaries. Definitive drug testing is a known landing zone.
- Internal chart audit cadence. Quarterly, statistically valid sampling. Not vibes. Not AI-only. Human auditors who can read a treatment plan against the bill and tell you whether it holds.
- Compliance committee minutes. When Carelon’s letter arrives, the first thing requested will be your compliance program documentation. If your committee has not met in six months, you are starting from behind.
Other Payers Will Copy This Playbook
Elevance is not the only payer doing this; it is the one being explicit about it. Carelon Insights leadership changes announced in March 2026 named Will Feest President of Carelon Insights with a stated focus on advancing analytics-driven performance. UnitedHealth’s Optum, Centene, Molina, and the regional Blues plans all run comparable programs.
The GAO has flagged that CMS’s improper payment estimate for Medicaid managed care does not include a review of payments from managed care plans to providers, and that GAO and HHS-OIG have identified program integrity risks in those payments. That gap is exactly what payers are now closing with their own analytics. State Medicaid agencies will lean on plans to do this work. Plans will lean on you.
The operators who handle this well will not be the ones with the loudest compliance language on their website. They will be the ones whose clinical documentation, utilization management, and billing line up so cleanly that an analytics outlier flag resolves on first medical-record review. That is the goal: be boring on the dashboard.
Frequently asked questions
What did Elevance Health actually announce about behavioral health billing analytics?
On the January 28, 2026 Q4 earnings call, CEO Gail Boudreaux said Elevance will strengthen analytics to identify outlier utilization and billing patterns in high-cost SUD treatment settings, with follow-through via provider education, enhanced claims review, and payment accuracy and compliance initiatives. President Felicia Norwood specifically called out behavioral health and ABA spending as drivers of inflated utilization. The work is being run primarily through Carelon Insights, Elevance’s payment integrity business.
How big is the documentation problem Elevance and CMS are looking at?
CMS reported a FY2024 Medicaid improper payment rate of 5.09%, equal to $31.10 billion, and 79.11% of those improper payments stemmed from insufficient documentation. That is the lever payers pull first because it requires no fraud finding, just a records gap. Behavioral health programs with weak documentation against ASAM Criteria, 4th Edition placement and medical necessity are the first to surface in outlier reports.
Which behavioral health services are most likely to be flagged first?
Expect early focus on residential SUD treatment (ASAM Levels 3.5 and 3.7), partial hospitalization (Level 2.5, which is outpatient), intensive outpatient (Level 2.1), definitive drug testing, and ABA. HHS-OIG previously found a 58.9% improper payment rate for the highest-cost Medicare drug test code, and the OIG has issued audit reports recommending tens of millions in repayments from states including Colorado ($77.8M, ABA) and Maine ($45.6M, autism services). Carelon’s models will mirror those federal targets.
What should a multi-state behavioral health operator do in the next 90 days?
Run a focused internal audit on medical necessity documentation tied to ASAM Criteria, 4th Edition, length-of-stay defensibility against payer benchmarks, billing-code intensity for H-codes and drug testing units, and utilization management notes. Convene the compliance committee, document it, and pre-build an audit response playbook so the first Carelon letter does not catch the leadership team flat-footed. The goal is to be unremarkable on the payer’s outlier dashboard.
References
- Elevance Health Q4 2025 Earnings Call Transcript (Motley Fool, January 28, 2026)
- Behavioral Health Business: Elevance Health Eyes ABA, SUD in Looming Behavioral Health Cost Savings Effort
- Elevance Health: How AI Helps Fight Fraud, Waste, and Abuse
- Elevance Health Newsroom: Leadership Appointments (March 2026)
- CMS Fiscal Year 2024 Improper Payments Fact Sheet
- HHS-OIG: Colorado Made at Least $77.8 Million in Improper Medicaid Payments for ABA
- HHS-OIG: Maine Made at Least $45.6 Million in Improper Medicaid Payments for Autism Services
- HHS-OIG: Improper Payments for Drug Testing Services (2021)
- GAO-25-107770: Medicaid Managed Care Improper Payment Estimate
- Ohio Auditor: Nearly $2 Million in Improper Medicaid Payments to Behavioral Health Agency (December 2025)